The global eye drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Eye drugs are used for the treatment of eye-related disorders such as infections, diabetic retinopathy, among others. The major factor driving the demand for the global eye drug market during the forecast period is the new product launches across the globe. 

For instance, in October 2021, Allergan announced the approval of VUITY (pilocarpine HCl ophthalmic solution) 1.25% from the US Food and Drug Administration (FDA) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. Additionally, in September 2021, Samsung Bioepis announced the approval of Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) from the US FDA. It is used for the treatment of several eye diseases and conditions, including neovascular (wet) age-related macular degeneration (nAMD).

Some major players in the market include Allergan plc, Mylan NV, and Bausch & Lomb Co., Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, NovaBay announced the launch of Avenova lubricating eye drops. It is used for the treatment of dry eye symptoms.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By End-User

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- Allergan plc, Mylan NV, and Bausch & Lomb Co., Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Eye Drug Market Report by Segment

By Type

• Drops
• Tablets and Capsules

By End-User

• Glaucoma
• Retinal Disease
• Bacterial Infection
• Others

Global Eye Drug Market Report by Region

North America

United States

Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa